ASX200 slips as healthcare boom fails to offset bank losses
Surging healthcare stocks and a boost from the world largest miner was unable to lift the Australia sharemarket…
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
– 94% of patients (51 of 54) remained free from the burden of continuous prophylaxis treatment through five…